Delivering health care at the grassroots level and asking how it can be done better were the focus of a panel discussion Monday involving experts from across the country.

A bipartisan health bill would slightly decrease the deficit over 10 years and there would be no significant reduction in the number of people with insurance, according to the Congressional Budget Office.

Recent indications that the Trump administration is seeking to slash approximately $5.8 billion from the National Institutes of Health budget has touched off debate about public versus private medical research and the impact those budget cuts could have on the development of new therapies and medicines to treat patients.

Speculation that Republican Senate leaders will draft a health care bill that is hugely different than the measure that passed the House is "vastly overstated," Tom Miller, a resident fellow at the American Enterprise Institute, said.

The U.S. House could vote as early as this week on a revised health care bill following the filing of amendments designed to bridge the gap between different camps that led to an earlier version being pulled before a vote.

The nominee to lead the Food and Drug Administration faced questions today over his business connections to health care and pharmaceutical companies and promised lawmakers he would be an "impartial and passionate advocate for public health."

In the weeks leading up to the collapse of the American Health Care Act, health policy expert Joseph Antos warned Republicans to take their time and improve of some of the provisions in the bill.

While debate continues regarding the repeal or revision of the Affordable Care Act (ACA), lawmakers need to reassure insurance companies that their market will exist in 2018 and beyond, according to a health care law professor and writer.

The American Enterprise Institute recently published an article examining the e-cigarette industry, particularly striving to determine whether the haze surrounding public perception of the business is as pervasive as it was one year ago.

As health care issues took center stage in Washington Wednesday, physicians and policy experts are evaluating the nomination of Rep. Tom Price (R-GA) as secretary of Health and Human Services.

Republicans intent on making changes to the Affordable Care Act (ACA) will find it difficult to alter the way Medicare is delivered, according to experts watching closely what might happen with the new Trump administration.

House Speaker Paul Ryan recently laid out a health care plan that would serve as a Republican alternative to Obamacare, leaving some of the health care law’s current provisions in place and replacing the less popular ones.

The U.S. House Committee on Energy and Commerce recently held a hearing to evaluate health care solutions that promote consumer choice and innovation in how health care plans are designed.

Six years after the passage of the Affordable Care Act (ACA), more commonly referred to as Obamacare, an expert has pointed out that the Obama administration’s claim that ACA benefits millions of Americans is true, but exaggerated.

As the rate of business startup activity in the United States flatlines, changes in national health policy, among others, could help turn around the situation, an American Enterprise Institute (AEI) expert said last week.

Democratic candidate Hillary Clinton announced in late September that she would demand a stop to excessive profiteering and marketing costs by encouraging innovation and new treatments from drug companies — including a stop to direct-to-consumer drug company advertising subsidies — and reinvesting funds in research.

The Congressional Budget Office recently lowered the health care enrollment projections for 2016 by almost 40 percent. James Capretta, senior fellow at the American Enterprise Institute, said this reduction can be explained by previous projections that were unrealistically high.

Dr. Scott Gottlieb recently spoke to the International Society for Stem Cell Research in Berkeley, California, to address how the FDA needs to adapt its approach to pre-market regulations of novel areas of technology -- such as gene therapy -- focusing on measures of risk rather than clinical applications.

Recent discussions about the antiquities of Medicare and how it is shaping the future of health care have been heating up, especially with respect to Obamacare reform and Medicare’s place within the system. The American Enterprise Institute (AEI) is one organization that has called for Medicare reform, emphasizing its importance.

A recent report was issued by the American Enterprise Institute (AEI), which laid out an agenda for the reform of health and health care, offering ways to redirect health care to more efficient practices in the wake of the Affordable Care Act (ACA).